ASPC 2018 Congress on CVD Prevention
Avatar

Comprehensive Approach to Lowering CVD Risk in Diabetics

By ASPC 2018 Congress on CVD Prevention FEATURING Yehuda Handelsman
By ASPC 2018 Congress on CVD Prevention FEATURING Yehuda Handelsman
779 views
August 10, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

04:47
Novartis Cardiology

Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowe…

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Recommended

AUTOPLAY
06:38

What Does Elevated Troponin Mean in COVID-19?

Allan Jaffe

80.8K views
47:11

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Houston Methodist

G. Davis

62.3K views
16:57

Ambulatory Blood Pressure Monitoring

William White

50.4K views
64:45

Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

44.0K views
20:48

Cardiac CT in 2023: From Anatomy to Physiology to Plaque Burden and …

Michael Gallagher

29.7K views
10:12

AHA 2022: Chlorthalidone Compared to Hydrochlorothiazide for the Pre…

AHA 2022 Conference Coverage

A. Ishani

27.8K views
11:37

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

22.2K views
11:25

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

20.6K views
28:13

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

19.8K views
17:21

Obesity and Diabetes in Children

Ilene Fennoy

18.8K views
27:14

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

14.0K views
15:40

ACC 2022: Triple Therapy - When to Use and How Long

ACC 2022 Conference Coverage

D. Kumbhani

13.0K views
18:43

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

12.2K views
15:06

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

8.8K views
12:26

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

11.3K views
26:01

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

9.5K views
08:35

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

7.3K views
17:44

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

8.5K views
27:24

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

8.6K views
45:45

Directions of Cardiology in the Next Decade: 2022-2032

Houston Methodist DeBakey Heart and Vascular Center

E. Braunwald

8.5K views